Status:
UNKNOWN
Safety and Effectiveness Study of Tumor Cell-derived Microparticles to Treat Malignant Ascites and Pleural Effusion
Lead Sponsor:
Huazhong University of Science and Technology
Conditions:
Malignant Pleural Effusion,
Malignant Ascites
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
Malignant ascites and pleural effusion are common symptoms in patients with advanced cancer. Currently, the management of malignant ascites and pleural effusion is a considerable clinical challenge. T...
Detailed Description
Ascites or pleural effusion were first removed from patients. The patients were then locally injected with microparticles packaging chemotherapeutic drugs 4 times a week. The therapeutic effects and s...
Eligibility Criteria
Inclusion
- Clinical diagnosis of malignant ascites or malignant pleural effusion
Exclusion
- Non-malignant ascites or pleural effusion
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2014
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT01854866
Start Date
May 1 2013
End Date
March 1 2014
Last Update
October 1 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hubei Provincial Traditional Chinese Medical Hospital
Wuhan, Hubei, China, 430070